Ameliorative Effect of Ginsenoside Rc on 5-Fluorouracil-Induced Chemotherapeutic Intestinal Mucositis via the PI3K-AKT/NF-κB Signaling Pathway: In Vivo and In Vitro Evaluations
Liyue Xu, Xiaolan Zhao, Fei Tang, Jingnan Zhang, Cheng Peng, Hui Ao, Massimo Nabissi · 2024
Read Ameliorative Effect of Ginsenoside Rc on 5-Fluorouracil-Induced Chemotherapeutic Intestinal Mucositis via the PI3K-AKT/NF-κB Signaling Pathway: In Vivo and In Vitro Evaluations by Liyue Xu, Xiaolan Zhao, Fei Tang, Jingnan Zhang, Cheng Peng, Hui Ao, Massimo Nabissi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642520.txt.
Description
Liyue Xu and co-authors study, in twenty twenty-four, a ginseng compound that may ease gut damage from a common cancer drug. The drug, 5-fluorouracil, often inflames the gut lining, a side effect called mucositis. The compound, ginsenoside Rc, is known for calming swelling and oxidative stress. The team tested it in mice and in gut cells in the lab. They tracked weight loss, diarrhea, gut leakiness, and tissue damage in mice. Network analysis of drug targets hinted at the pathways involved.
The compound cut weight loss, diarrhea, and gut damage in treated mice. In cells, it lowered inflammatory signals, cell death, and leakiness. A pathway that controls swelling and survival was implicated by protein tests.
Catalog record
| CREATOR | Liyue Xu, Xiaolan Zhao, Fei Tang, Jingnan Zhang, Cheng Peng, Hui Ao, Massimo Nabissi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |